Skip to main content
. 2016 Nov 4;8(12):18773–18791. doi: 10.18632/oncotarget.13095

Figure 7.

Figure 7

Hsa-miR-147b-5p as biomarker for the median survival of ovarian cancer patients. Prolonged survival time of ovarian cancer patients expressing hsa-miR-147b-5p. Kaplan-Meier plots of the groups with tumors expressing hsa-miR-147b-5p at low (blue) and high (red) levels. The median survival time of the low-expressors was 25 months and that of the high-expressors 36.1 months.